Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
Healthcare | Drug Manufacturers - Major | USA
statements
IndexDJIA S&P500 P/E13.99 EPS (ttm)2.72 Insider Own0.03% Shs Outstand5.55B Perf Week-1.55%
Market Cap211.06B Forward P/E13.18 EPS next Y2.89 Insider Trans-8.72% Shs Float5.53B Perf Month1.47%
Income15.42B PEG3.28 EPS next Q0.57 Inst Own73.50% Short Float0.93% Perf Quarter4.19%
Sales53.04B P/S3.98 EPS this Y-11.90% Inst Trans-1.54% Short Ratio2.69 Perf Half Y-11.39%
Book/sh11.74 P/B3.24 EPS next Y-2.30% ROA10.10% Target Price41.45 Perf Year-15.75%
Cash/sh1.64 P/C23.23 EPS next 5Y4.27% ROE26.30% 52W Range33.97 - 44.99 Perf YTD-12.88%
Dividend1.44 P/FCF62.93 EPS past 5Y1.00% ROI10.20% 52W High-14.99% Beta0.65
Dividend %3.79% Quick Ratio0.70 Sales past 5Y0.80% Gross Margin80.30% 52W Low12.58% ATR0.57
Employees92400 Current Ratio0.90 Sales Q/Q-4.60% Oper. Margin36.70% RSI (14)58.26 Volatility1.17% 1.38%
OptionableYes Debt/Eq0.81 EPS Q/Q98.20% Profit Margin30.60% Rel Volume0.48 Prev Close38.03
ShortableYes LT Debt/Eq0.55 EarningsOct 29 BMO Payout48.70% Avg Volume19.18M Price38.24
Recom2.50 SMA201.59% SMA503.37% SMA200-3.55% Volume7,833,711 Change0.57%
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
Dec-06-19 09:27AM  Pharma Stock Roundup: FDA Updates for RHHBY, AZN, MRK, No Asbestos in Talc Says JNJ Zacks
08:32AM  Glaxo Files NDA for Fostemsavir for Heavily Pre-Treated HIV Zacks
Dec-05-19 08:50PM  After Biogen's big Alzheimer's drug data reveal, observers remain divided American City Business Journals
09:58AM  Bristol-Myers' Orencia Gets Breakthrough Therapy Tag for GvHD Zacks
Dec-04-19 05:52PM  Bayer and Teva Double Down on Worst M&A Deals of Decade GuruFocus.com
10:00AM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
09:00AM  Pfizer Stock Is A Top Pharma Company But Should You Buy It? Investor's Business Daily
03:55AM  Pfizer/Astellas Xtandi Gets Nod in China for Prostate Cancer (Revised) Zacks
Dec-03-19 09:38AM  Mylan (MYL) Launches Herceptin Biosimilar Ogivri in the US Zacks
09:31AM  Gene-Therapy Firm Audentes Sells for Double Its Share Price. It Could Be the First of Many More Deals. Barrons.com
09:24AM  Merck's Keytruda Gets FDA's Priority Tag in Bladder Cancer Zacks
08:17AM  Large-Cap Pharmaceuticals Industry Prospects Bright for 2020 Zacks
Dec-02-19 08:30AM  AstraZeneca's (AZN) Imfinzi Gets FDA Priority Tag for SCLC Zacks
07:00AM  Heart Drugs Are Having a Moment Bloomberg
Nov-30-19 05:44PM  Is Pfizer Inc. (PFE) A Good Stock To Buy ? Insider Monkey
Nov-29-19 08:48AM  China Negotiates Bargain Prices With Big Pharma Barrons.com
08:13AM  Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates Benzinga
Nov-28-19 09:31AM  Why Is Pfizer (PFE) Up 0.4% Since Last Earnings Report? Zacks
08:44AM  Here's Why Merck's (MRK) Shares Are Up This Year Zacks
Nov-27-19 09:26PM  UK regulator seeks to reinstate £90m fine against Pfizer and Flynn Financial Times
11:34AM  Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050 PR Newswire
10:12AM  Merck's Keytruda Gets Nod in China for Difficult Lung Cancer Zacks
10:05AM  FOCUS-Pfizer, Novartis lead $2 bln spending spree on gene therapy production Reuters
10:00AM  Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire
07:14AM  Pfizer, Novartis lead $2 billion spending spree on gene therapy production Reuters
07:10AM  Pfizer/Astellas Xtandi Gets Nod in China for Prostate Cancer Zacks
07:07AM  Pfizer, Novartis lead pharma spending spree on gene therapy production Reuters
Nov-25-19 07:00PM  Astellas Announces the Approval of XTANDI® (enzalutamide) by the China National Medical Products Administration (NMPA) PR Newswire
09:44AM  The Zacks Analyst Blog Highlights: Pfizer, Netflix, Dominion, Costco and Charles Schwab Zacks
08:24AM  Pfizer Has 5 Drugs in Its Pipeline That Could Turn Its Stock Around Barrons.com
07:08AM  3 Health Care ETFs Hitting New Highs Benzinga
05:04AM  The Chinese Vape Market Is Booming. But Heavy Regulation Is Coming. Barrons.com
Nov-24-19 10:08PM  Here is the 22nd Most Popular Stock Among 752 Hedge Funds Insider Monkey
07:15PM  Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050 PR Newswire
Nov-23-19 03:42PM  Barron's Picks And Pans: Pfizer's New Identity, Electric Vehicles, Hong Kong Exodus And Is The Bull Market About To End? Benzinga
03:41PM  Pfizer Is the Dows Worst Stock. A New Strategy Makes It Worth Another Look. Barrons.com
01:54AM  [video]Top 5 Stock Market Movers in the Dow Jones This Week TheStreet.com
Nov-22-19 05:09PM  US Indexes Higher Friday, but Down for the Week GuruFocus.com
04:31PM  Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow InvestorPlace
01:59PM  Top Research Reports for Pfizer, Netflix & Dominion Energy Zacks
12:07PM  [video]Top 5 Stock Winners in the Dow Jones Industrial Average This Week TheStreet.com
10:57AM  Pharma Stock Roundup: FDA Nod to NVS' & AZN's Drugs, BMY-CELG Merger Closes Zacks
10:29AM  BioMarin Files MAA to EMA for Gene Therapy of Hemophilia A Zacks
09:43AM  Amgen (AMGN) Completes Otezla Buyout, Raises 2019 Guidance Zacks
09:41AM  NewsBreak: Trump Looks to Let Florida, Others Import Prescription Drugs Investing.com
Nov-21-19 05:55PM  US Indexes Close Lower Thursday GuruFocus.com
02:41PM  Biogen, Novartis named in settlement between foundation, federal prosecutors American City Business Journals
11:00AM  Top Health Care Stocks for December 2019 Investopedia
10:00AM  Merck's Keytruda Wins EU Nod for First-Line Head/Neck Cancer Zacks
Nov-20-19 03:56PM  Dow falls 100 points on losses for shares of Home Depot, 3M MarketWatch
12:58PM  Dow's 175-point drop led by losses for shares of Home Depot, Apple Inc. MarketWatch
12:57PM  Dow down 175 points on losses for shares of Home Depot, Apple Inc. MarketWatch
09:53AM  Dow falls 75 points on losses for 3M, Pfizer shares MarketWatch
Nov-19-19 04:05PM  Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx) GlobeNewswire
10:23AM  Pfizer Gets FDA Approval for Biosimilar of AbbVie's Humira Zacks
09:31AM  Aerie to Acquire Dry Eye Disease-Focused Pharma Avizorex Zacks
08:57AM  How Pfizer (PFE) Stock Stands Out in a Strong Industry Zacks
12:00AM  Our Ultimate Stock-Pickers' Top 10 High-Conviction and New-Money Purchases Morningstar
Nov-18-19 10:11AM  Stock Market News for Nov 18, 2019 Zacks
06:45AM  FDA Approves Pfizers Biosimilar, ABRILADA (adalimumab-afzb) for Multiple Inflammatory Conditions Business Wire
05:00AM  Pfizer- A Stealth Blockbuster in Heart Drugs MoneyShow
Nov-17-19 03:40PM  AbbVie's Humira on Pace to Become Biggest Seller by 2024 GuruFocus.com
Nov-16-19 12:30AM  3 Things Under the Radar This Week Investing.com
Nov-15-19 05:47PM  US Indexes Close Higher Friday and for the Week GuruFocus.com
04:31PM  Dow Jones Today: Stocks Climb on U.S.-China Trade Developments InvestorPlace
02:44PM  Dow's 175-point jump led by gains in shares of UnitedHealth, Pfizer MarketWatch
09:00AM  Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals Business Wire
07:45AM  3 Big Stock Charts for Friday: Snap, Pfizer and Splunk InvestorPlace
07:12AM  Pharma Stock Roundup: MRK, GSK, ABBV, LLY's Pipeline & Regulatory Updates Zacks
06:41AM  4 Big Drugmakers to Bet on After a Great Earnings Season Zacks
Nov-13-19 03:43PM  UPDATE 1-J&J blockbuster loses ground to biosimilars despite Quebec court ruling Reuters
02:34PM  Should Investors Add Johnson & Johnson Stock to Their Shopping Lists? InvestorPlace
09:30AM  Abbott Labs Chooses an Insider to Be Its New CEO Barrons.com
03:23AM  CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc. GlobeNewswire
01:00AM  J&J's Remicade losing ground in Quebec health plan despite court victory Reuters
Nov-12-19 12:15PM  Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination PR Newswire
06:45AM  Pfizer Announces Results of Phase 3 Study for XELJANZ® (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting Business Wire
Nov-11-19 04:23PM  Pfizer-Merck KGaA's Bavencio Fails in 2nd Gastric Cancer Study Zacks
10:16AM  Walgreens' stock surge providing a 25-point cushion to the Dow's price MarketWatch
Nov-08-19 08:41AM  Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial MarketWatch
08:00AM  Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial CNW Group
08:00AM  EMD Serono and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial PR Newswire
Nov-07-19 02:20PM  David Carlson Trims Charles Schwab, Exits Verizon GuruFocus.com
10:51AM  Aerie (AERI) Q3 Loss Wider, Sales Beat, Guidance Slashed Zacks
05:32AM  [video]Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price Target TheStreet.com
Nov-06-19 09:20AM  Pfizer Beats Earnings as Weekly Chart Stays Positive Investopedia
Nov-05-19 01:12PM  Coury on Mylan merger: 'We're moving the company to something quite different" American City Business Journals
12:37PM  Mylan shares slide 5.5% as CFRA downgrades to sell from hold MarketWatch
11:41AM  Mylan's (MYL) Q3 Earnings Beat Estimates, Revenues Miss Zacks
11:01AM  Which Companies Recently Raised Guidance? Yahoo Finance
09:27AM  Mylan Doles Out the Right Prescription for Investors TheStreet.com
07:27AM  UPDATE 3-Mylan shares slide after warning of hit to revenue Reuters
07:07AM  Mylan tops profit estimates as newer drugs spur North America growth Reuters
07:07AM  Mylan shares slide after warning of hit to revenue Reuters
Nov-04-19 12:28PM  Marine algae keys Chinese claim to Alzheimers breakthrough MarketWatch
11:10AM  The Zacks Analyst Blog Highlights: Pfizer, Merck, Bristol-Myers and Glaxo Zacks
10:01AM  5 Large-Cap Stocks Are Up More Than 100% This Year GuruFocus.com
01:00AM  Rounding Up Big Pharma Earnings Morningstar
Nov-01-19 02:16PM  The Good, Bad, and Ugly for Biogen Stock InvestorPlace
11:55AM  Pharma Stock Roundup: MRK, PFE, GSK, BMY Q3 Earnings, Other Updates Zacks
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as Merck KGaA, Nektar Therapeutics, and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PFIZER INC10% OwnerSep 17Buy18.0050,000900,0004,593,847Sep 19 04:19 PM
Gottlieb ScottDirectorAug 23Buy34.723,000104,1603,000Aug 26 09:27 AM
DAMELIO FRANK AExecutive Vice PresidentJul 02Sale44.09153,1846,753,385337,392Jul 03 04:06 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM
open in yahoo | open in reuters | open in google